Table 2 Patient characteristics (percentage or standard deviation in parentheses)

Sex

 Female

237 (49.4%)

163 (49.4%)

74 (49.3%)

 Male

243 (50.6%)

167 (50.6%)

76 (50.7%)

Age (years)

 Mean

41.6

42.5

39.3

 Range

6–76

6–76

9–69

Severity of the allergic reaction

 Grade I

10 (2.1%)

4 (1.2%)

6 (4.0%)

 Grade II

33 (6.9%)

23 (7.0%)

10 (6.7%)

 Grade III

256 (53.3%)

171 (51.8%)

85 (56.7%)

 Grade IV

180 (37.5%)

131 (39.7%)

49 (32.7%)

Latency time (min)

 Mean

13.0 (± 14.9)

12.4 (± 13.5)

14.7 (± 17.9)

Cutaneous symptoms

 Yes

326 (67.9%)

224 (67.9%)

102 (68.0%)

 No

99 (20.6%)

70 (21.2%)

29 (19.3%)

 Missing

55 (11.5%)

36 (10.9%)

19 (12.7%)

Mean sIgE (kU/l)

 To honeybee venom (i1)

6.07 (± 15.5)

1.45 (± 5.5)

17.31 (± 23.9)

 To rApi m 1

2.30 (± 10.2)

0.11 (± 0.3)

7.86 (± 18.1)

 To wasp venom (i3)

9.13 (± 21.4)

12.28 (± 24.6)

1.34 (± 2.8)

 To rVes v 1

5.71 (± 21.0)

7.59 (± 24.2)

0.42 (± 1.3)

 To rVes v 5

7.34 (± 18.1)

9.80 (± 20.7)

0.77 (± 2.8)

BST level

 Measured

437

307

130

 Normal (< 11.4 µg/l)

402 (92.0%)

277 (90.2%)

125 (96.2%)

 Elevated (≥ 11.4 µg/l)

35 (8.0%)

30 (9.8%)

5 (3.8%)

Intracutaneous test

 Performed

428

300

128

 0.00001 µg/ml

66 (15.4%)

40 (13.3%)

26 (20.3%)

 0.0001 µg/ml

3 (0.7%)

3 (1.0%)

0 (0.0%)

 0.001 µg/ml

69 (16.1%)

52 (17.3%)

17 (13.3%)

 0.01 µg/ml

150 (35.0%)

111 (37.0%)

39 (30.5%)

 0.1 µg/ml

98 (22.9%)

70 (23.3%)

28 (21.9%)

 1 µg/ml

35 (8.2%)

22 (7.3%)

13 (10.2%)

 Negative

7 (1.6%)

2 (0.7%)

5 (3.9%)